Liquid Pharmaceutical & Biotechnology Expertise

Product description

Drug production and the manufacture of active pharmaceutical ingredients (APIs) demands the very highest product quality and purity standards, as well as validated manufacturing processes. As a supplier of sterile process plant with many years of experience, GEA can draw upon the comprehensive theoretical knowledge and expertise of its engineers to provide modern, bespoke and cost effective process technology to manufacture new medicines according to cGMP guidelines and US FDA, SFDA and EMA requirements. The process lines provided by GEA have a proven track record in API production, including fermentation, clarification, separation, homogenization, crystallization, concentration, lyophilization and fractionation. Our standalone machines or package units guarantee a high yield of valuable substances and operate trouble-free, efficiently, reliably and economically throughout a long service life.
Read more

More products from GEA Group

View all our products (12)

Products from other suppliers